-Newsclick.in It appears the stage is being set to scuttle India and South Africa’s IP waiver proposal with regard to Covid vaccines and technology ahead of the 12th WTO Ministerial this month-end. At various global fora, Big Pharma and rich countries have been steadfastly pushing the focus toward supply-side bottlenecks of vaccines and unequal distribution of doses in a bid to steer the discourse away from the more contentious issue of patents...

-The Hindu Business Line WTO has allowed countries to issue compulsory licenses during emergencies A Division Bench of the Kerala High Court on Tuesday asked the Centre to respond to a plea for invoking the compulsory licensing to allow other capable vaccine manufacturers to produce Covid vaccines. The Bench comprising Justice Raja Vijayaraghavan and Justice M.R.Anitha passed the directive when a public interest litigation in this regard came up for hearing. The petition...

In the month of April this year, there has been an unprecedented upsurge in daily new cases and daily new deaths in the country due to Covid-19. States, which reported large increases in daily new cases and daily new deaths, are Maharashtra, Kerala, Karnataka, Delhi and Uttar Pradesh, to name but a few.   Data accessed from https://www.covid19india.org/, which is a crowdsourced platform and an independent aggregator of daily Covid-19 figures and...

-The Hindu Survey cites logistics issues and absence of orders, among others, as reasons Chennai: About 71% of the MSME establishments were unable to pay either partially or fully the wages due for March 2020 either due to logistics issue or absence of orders, among other issues, according to All India Manufacturers Organisation (AIMO). AIMO, which is an apex trade body focused on the interests of the MSME sector, surveyed over 5,000 traders/MSMEs...

-The Hindu CDSCO sends letter to manufacturers Alerted by the Union Health Ministry’s pharmaceutical watchdog, the National Co-ordination Centre of the Pharmacovigilance Programme of India (PvPI), on adverse reactions that were being reported from some commonly-used antibiotics, the Central Drugs Standard Control Organisation (CDSCO) has now asked manufacturers to ensure that this information be made available to the general public. CDSCO has written to drug manufacturers, to mention in leaflets inserted into drug...